These findings established PDCD10 as a tumor suppressor-like factor in glioblastoma, and triggered our strong interest in gaining detailed insights into the underlying mechanism of PDCD10-dependent TMZ sensitivity using our established, acute, acquired TMZ-resistance model as a basis [13]. The gene discussed is PDCD10; the disease is glioblastoma.